Bayer Animal Health and Paraco agree on access to lead molecules

20-Jul-2010 - New Zealand

Bayer Animal Health GmbH and Paraco Technology Limited, a 100% owned subsidiary of AgResearch, New Zealand’s largest Crown Research Institute, announced they have signed an option agreement allowing Bayer exclusive access to Paraco’s current lead molecules for testing and development in animal health. The focus in the foreseen activities lies in the research of parasiticides.

Dr Peggy Dillender, Global Head of acquisitions and licensing at Bayer Animal Health, said that Bayer were pleased to sign the agreement with Paraco and to tap into some of the innovative animal health research being conducted in New Zealand. “We hope this will be the beginning of a long and fruitful relationship between Bayer, Paraco and indirectly AgResearch,” said Dr Dillender.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances